Reolysin® Enters Clinical Trial for Patients With Metastatic Colorectal Cancer

Immunotherapy - United Kingdom
doi 10.2217/1750743x.1.2.167
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Future Medicine Ltd